Institutional Ownership
Madrigal Pharmaceuticals Inc
CUSIP 558868105COMMDGLQ1 2026
13D / 13G Filings
58
Schedule 13D/13G on record
Beneficial Filers
17
Distinct reporting persons
Largest Stake
27.9%
Max % of class reported
Institutional Holders
369
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
58 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | Janus Henderson Group PLC | 13G/A | 7.0% | 1.58M | SEC |
| 2 | Feb 17, 2026 | Paulson &Amp; Co. Inc. | 13G/A | 7.5% | 1.71M | SEC |
| 3 | Dec 12, 2025 | Rebecca Taub, M.D. | 13D/A | 7.8% | — | SEC |
| 4 | Dec 12, 2025 | Paul A Friedman, M.D. | 13D/A | 7.8% | — | SEC |
| 5 | Dec 12, 2025 | Rebecca Taub, M.D. | 13D/A | 7.8% | — | SEC |
| 6 | Dec 12, 2025 | Paul A Friedman, M.D. | 13D/A | 7.8% | — | SEC |
| 7 | Nov 14, 2025 | Janus Henderson Group PLC | 13G/A | 8.3% | 1.84M | SEC |
| 8 | Aug 14, 2025 | Janus Henderson Group PLC | 13G/A | 9.9% | 2.19M | SEC |
| 9 | May 14, 2025 | Janus Henderson Group PLC | 13G/A | 10.0% | 2.21M | SEC |
| 10 | Feb 14, 2025 | Janus Henderson Group PLC | 13G/A | 10.1% | 2.21M | SEC |
48 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Madrigal Pharmaceuticals Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Baker Bros. Advisors LP | 2.14M | $1.12B |
| 2 | Janus Henderson Group PLC | 2.02M | $1.05B |
| 3 | Rtw Investments, LP | 1.99M | $1.04B |
| 4 | Avoro Capital Advisors LLC | 1.82M | $951.76M |
| 5 | Blackrock, Inc. | 1.56M | $816.59M |
| 6 | Paulson & Co. Inc. | 1.39M | $728.77M |
| 7 | Wellington Management Group LLP | 695.0K | $363.79M |
| 8 | State Street Corp | 609.5K | $319.07M |
| 9 | Fmr LLC | 511.7K | $267.87M |
| 10 | Geode Capital Management, LLC | 455.9K | $238.68M |